share_log

圣湘生物科技股份有限公司关于2023年年度报告信息披露监管问询函的回复公告

Announcement of Sansure Biotech Inc.'s reply to the regulatory inquiry letter regarding the disclosure of information in the 2023 annual report.

Sensex a share ·  Jun 7
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more